A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/lJnKWAkeKi @NatureMedicine https://t.co/vLMT3iKTtF
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Feb 2024 – Nov 2025Where it's discussed
-
News172 articles
-
X / Twitter98 posts
-
Blogs11 articles
-
Facebook10 posts
-
YouTube4 videos
-
Reddit4 posts
AI synopsis
What people are saying
The group generally perceives the research as impactful, with posts using words like 'concerning' and 'significant', emphasizing the potential risks of high niacin intake. Many examples highlight how the metabolic pathway may influence cardiovascular health, reflecting both curiosity and concern about implications for supplement use and treatment protocols.
Most posts recognize the findings as significant and support the idea that niacin metabolites are linked to vascular inflammation and cardiovascular risk.
Posts show high interest, with many discussing the potential health implications and the need to reconsider niacin use.
Several discussions reference detailed mechanisms and studies, indicating moderate deep engagement, though some messages are more informational than analytical.
The discussions suggest the findings could influence public health recommendations and supplement usage, indicating high impact.
Abstract in brief
- This study found that certain metabolites produced from niacin, specifically 2PY and 4PY, are linked to increased risk of major adverse cardiovascular events (MACE) in cardiac patients.
- Higher levels of these metabolites are associated with increased levels of soluble vascular adhesion molecule 1 (sVCAM1), a marker related to vascular inflammation, and genetic variants influencing these metabolites also correlate with sVCAM1 levels.
- Experimentally, 4PY, but not 2PY, promotes vascular inflammation by increasing VCAM1 expression and leukocyte adherence in mice, suggesting that excessive niacin metabolites may contribute to vascular inflammation and cardiovascular risk.]
Top posts
Most liked on X and Blueskyナイアシンは安全とされてるけど 実際のところ注意が必要だと 僕は思っている ナイアシンの最終代謝物 2PY(N1-メチル-2-ピリドン-5-カルボキサミド )は、血管の炎症を促進し心血管疾患のリスクに寄与する メチル基に影響を与えるから 低メチはとくに注意が必要かな https://t.co/BqQvndgV4Y https://t.co/iMT7IJSzaL
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk | Nature Medicine https://t.co/VNwtf6yomZ
【ナイアシン過剰摂取でCVDリスク上昇?(Nat Med)】 米コホート1162人3年追跡 ナイアシン(ビタミンB3)誘導体血中濃度 第4四分位(vs1)でCVDリスク 調整 HR 2.8 (1.6-4.9) マウスでは過剰なナイアシンで血管内皮VCAM-1の発現増加し、白血球の接着を誘導する可能性 https://t.co/Bl3ZFmnQ02 https://t.co/AIkYjJUYxf
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk | Nature Medicine https://t.co/lE9NuyxNXP
All mentions
Niacin Metabolites and Heart Disease: Is There a Connection? Journal Findings
This study found that certain niacin-derived metabolites, 2PY and 4PY, are linked to increased cardiovascular risk and vascular inflammation, highlighting the need for careful evaluation of niacin's effects on heart…
Rethinking Cholesterol Treatment and the Impact of Niacin Metabolites on Heart Risk
This video explains current hypercholesterolemia treatments, including statins and newer drugs, their mechanisms, and effects on preventing heart attacks and strokes. It also discusses how niacin metabolites like 2PY…
Excess Vitamin B3 Metabolites and Cardiovascular Disease Risk
Cleveland Clinic researchers found that high levels of vitamin B3, or niacin, can cause inflammation and increase heart disease risk. Excess metabolites like 4PY promote vascular inflammation, highlighting the…
Niacin Metabolites and Cardiovascular Risk: An In-Depth Analysis
This episode critiques a study suggesting niacin metabolites may increase cardiovascular risk. It examines the study's methodology, highlighting potential biases and overlooked factors, and discusses how these…
@Will_of_Europa A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk | Nature Medicine https://t.co/tC2SGgqkCk https://t.co/NVTFYsT1S7
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
RT @nana306k: ナイアシンは安全とされてるけど 実際のところ注意が必要だと 僕は思っている ナイアシンの最終代謝物 2PY(N1-メチル-2-ピリドン-5-カルボキサミド )は、血管の炎症を促進し心血管疾患のリスクに寄与する メチル基に影響を与えるから 低メチは…
RT @nana306k: ナイアシンは安全とされてるけど 実際のところ注意が必要だと 僕は思っている ナイアシンの最終代謝物 2PY(N1-メチル-2-ピリドン-5-カルボキサミド )は、血管の炎症を促進し心血管疾患のリスクに寄与する メチル基に影響を与えるから 低メチは…
RT @nana306k: ナイアシンは安全とされてるけど 実際のところ注意が必要だと 僕は思っている ナイアシンの最終代謝物 2PY(N1-メチル-2-ピリドン-5-カルボキサミド )は、血管の炎症を促進し心血管疾患のリスクに寄与する メチル基に影響を与えるから 低メチは…
RT @nana306k: ナイアシンは安全とされてるけど 実際のところ注意が必要だと 僕は思っている ナイアシンの最終代謝物 2PY(N1-メチル-2-ピリドン-5-カルボキサミド )は、血管の炎症を促進し心血管疾患のリスクに寄与する メチル基に影響を与えるから 低メチは…
RT @nana306k: ナイアシンは安全とされてるけど 実際のところ注意が必要だと 僕は思っている ナイアシンの最終代謝物 2PY(N1-メチル-2-ピリドン-5-カルボキサミド )は、血管の炎症を促進し心血管疾患のリスクに寄与する メチル基に影響を与えるから 低メチは…
RT @nana306k: ナイアシンは安全とされてるけど 実際のところ注意が必要だと 僕は思っている ナイアシンの最終代謝物 2PY(N1-メチル-2-ピリドン-5-カルボキサミド )は、血管の炎症を促進し心血管疾患のリスクに寄与する メチル基に影響を与えるから 低メチは…
RT @nana306k: ナイアシンは安全とされてるけど 実際のところ注意が必要だと 僕は思っている ナイアシンの最終代謝物 2PY(N1-メチル-2-ピリドン-5-カルボキサミド )は、血管の炎症を促進し心血管疾患のリスクに寄与する メチル基に影響を与えるから 低メチは…
ナイアシンは安全とされてるけど 実際のところ注意が必要だと 僕は思っている ナイアシンの最終代謝物 2PY(N1-メチル-2-ピリドン-5-カルボキサミド )は、血管の炎症を促進し心血管疾患のリスクに寄与する メチル基に影響を与えるから 低メチはとくに注意が必要かな https://t.co/BqQvndgV4Y https://t.co/iMT7IJSzaL
B Nicotinamid ⛔️risk NAM - toxic pathway ⛔️ /// (Niacin mit Flush ist gut)
@ApoDudz @Pl4ntbased @REV_Insulin_Res "A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk" https://t.co/0ms5U9zXYs Fibrates are good are lowering trigs, but ApoB reduction is much less compared to statins. Makes sense because trigs contribute less to ApoB
REFERENCE: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/MzJugIXUZN
@mkaeberlein @CharlesMBrenner @OptispanPodcast A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk. How does this study from Nature impact your view on NMN or NR supplementation? https://t.co/R3as0MfJTB
Un análisis metabolómico no dirigido del plasma en ayunas de 1,162 pacientes cardiovasculares sugirió que el metabolismo de la Niacina se asociaba con incidentes de Eventos Cardiovasculares Adversos Mayores (MACE) a 3 años. Confirmado por 2 cohortes más. https://t.co/819wBbNZgM
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/Q9hfFDMddo
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/wnFkpnpu2l
I love research in nutrition, you never know what to think about the data! A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/rTSOVXpsij https://t.co/uwipIgof3t
RT @EARL_med_tw:
【ナイアシン過剰摂取でCVDリスク上昇?(Nat Med)】 米コホート1162人3年追跡 ナイアシン(ビタミンB3)誘導体血中濃度 第4四分位(vs1)でCVDリスク 調整 HR 2.8 (1.6-4.9) マウスでは過剰なナイアシンで血管内皮VCAM-1の発現増加し、白血球の接着を誘導する可能性 https://t.co/Bl3ZFmnQ02 https://t.co/AIkYjJUYxf
RT @Madam_Mito: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk | Nature Medi…
RT @Madam_Mito: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk | Nature Medi…
RT @Madam_Mito: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk | Nature Medi…
RT @Madam_Mito: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk | Nature Medi…
RT @Madam_Mito: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk | Nature Medi…
RT @Madam_Mito: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk | Nature Medi…
RT @Madam_Mito: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk | Nature Medi…
RT @Madam_Mito: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk | Nature Medi…
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk | Nature Medicine https://t.co/VNwtf6yomZ
Publisher Correction: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk #science #publication #research #journal https://t.co/d2chgNjsEZ
RT @Loose_Lab_Rat: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.…
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/wnFkpnpu2l cc @mcreynolds_lab
Publisher Correction: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/2acVbpLJI7 #MedicalAdvances #Labscience
Publisher Correction: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/vgjuEJos5l
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk @NatureMedicine Contributed by @ Marc Ferrell @ Hooman Allayee @ Stanley L. Hazen et al. https://t.co/GpOuHYq8A8
Trending on PubMed: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk. https://t.co/lVNrjiFQEV
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/65OGZxSUJr
A terminal metabolite of B Vitamin NIACIN promotes vascular inflammation and contributes to cardiovascular disease
Good things supplements are regulated! "A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk." https://t.co/Nh0UevliSP
New study reveals concerning link between excess niacin metabolism and increased cardiovascular disease risk. Could this explain the shift of NMN from dietary supplement to prescription substance?
@Vote_ForPedro @CaryKelly11 Very thorough paper. Feb 2024. https://t.co/BZYz1DE2ks
@CaryKelly11 Yeah, if you take B3, I'd read the paper if I were you. https://t.co/BZYz1DE2ks
@Drlipid This is kind of an irresponsible post. Imagine the fear you have put in people that are currently taking high dose niacin. Thank god someone broke it down for the masses. https://t.co/UmxToK3iIg https://t.co/GREwkPNp0V
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
Massive New Study shows Niacin and NAD+ cause Heart Disease?? Is this true? @Physionic_PhD https://t.co/AwnThUZ4oE
Massive New Study shows Niacin and NAD+ cause Heart Disease?? Is this true? https://t.co/5A7NUWG1bI
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk | Nature Medicine https://t.co/z7Zvaao2ud
Member publication alert: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/sAiCaNLbx3
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk - @NatureMedicine https://t.co/lLLN3ATt2g
RT @ccfvascmed: Excess vitamin B3 (niacin) was previously suggested to increase the risk of thrombotic CVA: https://t.co/L1tMcqbYEm. A new…
Here’s a link to the study I mentioned: https://t.co/lhDd04vxpy
@agingdoc1 @davidasinclair @Michael_petr @ScheibyeKnudsen doi: 10.1038/s41591-023-02793-8. Should we reconsider taking NMN and NR after this study?
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk | Nature Medicine https://t.co/lE9NuyxNXP
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/U9zZsvQBdR
Excess vitamin B3 (niacin) was previously suggested to increase the risk of thrombotic CVA: https://t.co/L1tMcqbYEm. A new molecular mechanism may explain this: https://t.co/YrKb37ia2R https://t.co/0V5fs6dfUM
@mkaeberlein @OptispanPodcast Ref: Ferrell, M., Wang, Z., Anderson, J.T. et al. A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk. Nat Med 30, 424–434 (2024). https://t.co/S5h8ewvp18 2/2
niacin flushers beware https://t.co/Eil3sG4Pow 'A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk'
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/larAswsXVY
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
@BradStanfieldMD PMID: 38374343 == https://t.co/bN2I1x6GME
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk | Nature Medicine https://t.co/iDxX7oFdul
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk - Nature Medicine https://t.co/R0uAKBrLR1
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
RT @agingdoc1: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/…
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk #science #publication #research #journal https://t.co/J1hJ4IYmra
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk https://t.co/lJnKWAkeKi @NatureMedicine https://t.co/vLMT3iKTtF
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk #science #publication #research #publications https://t.co/KaaUJ15XMp
RT @Prof_NickTalley: Bad news for niacin. A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular…
Bad news for niacin. A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk | Nature Medicine https://t.co/iHC9Ezy7zS
RT @gglinskii: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk. https://t.co…
RT @gglinskii: A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk. https://t.co…
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk | Nature Medicine https://t.co/7BzXg3eozv
@nick_krontiris FYI - A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk Nature Medicine (2024)
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk | Nature Medicine https://t.co/mcyISGB2wD
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk. https://t.co/5jUCWnhkA3
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk | Nature Medicine https://t.co/jIi96AzA8o
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk | Nature Medicine. La Niacina, Vit B utilizada para tratar desordenes de lípidos, causaría inflamación vascular y enf. Cardiovascular. https://t.co/CXLRSSqI8D
JR
よ